 |
|
|
|
|
SIO
SIO 2019 provides you the opportunity to share your research with more than 700 professionals in the global IO community and gain recognition from your peers. There are no restrictions on the number of abstracts you may submit or on the number of accepted abstracts you may present.
Note: SIO does not have a policy that limits prior presentation of data. SIO does not accept trials in progress.
All accepted abstracts will be featured on the SIO website and recognized in the SIO 2019 conference mobile app. All abstracts will be eligible for Best Abstract awards in Boston, and the top peer-reviewed abstract will be selected to present during a SIO 2019 plenary session. View abstract topics and submission guidelines online, and submit today!
SIO
Join SIO as we connect with the international IO community. The 4th China Conference on Microwave Ablation (CCMA 2019) and the 2nd SIO Symposium on Tumor Ablation will be held jointly in Nanjing, China, 4-6 January, 2019. As a strategic partner of CCMA, the Society of Interventional Oncology helped create the scientific program. The two conjoined meetings will feature cutting-edge education in a variety of formats, including: general plenary and specialized topic didactic lectures, "How I Do It" videos sessions, challenging case-based discussions, and poster presentations. Check out the Symposium Program Committee and faculty online, and register to attend today!
| Promoted by |
|
|
|
 |
SIO
 As the year comes to a close, it’s time to look ahead to an exciting 2019 for the Society of Interventional Oncology! Renew your membership today to secure your place among the most influential minds in this emerging field and demonstrate your commitment to advancing interventional oncology as well as to enjoy New Member Benefits!
Coming Soon: Case Spotlight! The Society of Interventional Oncology will be reintroducing Case of the Week — now called Case Spotlight! This is an opportunity for SIO members to share key findings from interesting patient cases within the interventional oncology community. Access to these biweekly cases and engagement in discussions will be available this month!
Conference Proceedings! Beginning in 2019, SIO members in 2019 will have complimentary access to the recordings from SIO’s Annual Scientific meeting! This resource, valued at $200, will be available to all members via their SIO accounts and will be released each year following the conference.
Be sure to renew your membership before 31 December 2018 to avoid a lapse in your member benefits including discounted SIO 2019 registration, opportunities to apply for exclusive research grants, free CME, and other year round benefits. Instructions for how to renew can be found here.
Journal of Cytology
To prospectively investigate the value of rapid on-site evaluation (ROSE) in transthoracic fine needle aspiration cytology (FNAC) of patients with pulmonary nodules. Computed tomography (CT)-guided FNA is commonly employed for the diagnosis of lung lesions and the most common reason for not being able to provide a diagnosis in FNA is inadequacy of samples. READ MORE
 |
|
Learn more about resorbable microspheres for targeted hypervascular tumor embolization
OptiSphere™ embolization spheres from Medtronic offer an alternative option for your patients.
Click here for more details. |
|
Academic Radiology
RATIONALE AND OBJECTIVES: There is lack of consensus on managing papillomas due to varied upgrade rates in the literature related to variability in the studied populations. We specifically studied upgrade rates of pure papilloma diagnosed with ultrasound core biopsy (UCB) using spring-loaded (SLB) and vacuum-assisted (VAB) biopsy devices in patients with low-to-intermediate pre-test probability for malignancy on imaging. READ MORE |
|
Diagnostic Cytopathology
Lung carcinoma is one of the commonest causes of cancer related death. Fine-needle aspiration cytology (FNAC) is a well-established technique in the diagnosis of various malignant tumors. FNAC is now an important technique in classifying lung carcinomas and also detecting salient mutational changes in lung carcinomas. The judicious use of the various immunological markers such as TTF-1, p40, CK 5/6, CK 7 and Napsin may help in sub-classification of non-small cell lung carcinomas (NSCLC). READ MORE
Hepatology Research
AIM: Although radiofrequency ablation (RFA) is an effective local treatment of hepatocellular carcinoma (HCC), local recurrence is relatively frequent. We aimed to elucidate the validity of salvage liver resection for recurrent HCC after RFA. METHODS: Patients who underwent liver resection for recurrent HCC after RFA (LR after RFA) and those who underwent second liver resection for recurrent HCC (Second LR) were included. The short-term outcomes were compared between the two groups. The survival rates between the two groups were compared after propensity-score matching to adjust for the variables, patient background, liver function, and tumor status. READ MORE |
| Cryotherapy is a minimally invasive treatment primarily for prostate, kidney and lung cancers as well as a palliative treatment for bone pain. It has been used since the 19th Century(see history below), but advancements continue to be made every year. Read more |
|
|
|
|
|
|
Polish Journal of Pathology
The aim of the study was the evaluation of the efficiency of cytological examination of the material obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound bronchoscope-guided fine needle aspiration (EUSB-FNA) methods in the diagnosis of lung carcinoma. The usefulness was also assessed of the material obtained in that way for immunocytochemical and molecular tests in the diagnosis of non-small cell lung carcinoma. READ MORE
Physics in Medicine and Biology
Fast prediction of the local thermal field induced by radiofrequency ablation (RFA) plays a critical role in hepatic RFA therapy. At present, it is still a challenging task to calculate and visualize the temperature distribution of RFA in real-time, especially when the heat-sink effect of adjacent large vessels is taken into account. To achieve this, the current investigation presented an analytical solution to calculate the temperature in RFA with an execution time of 0.05 s for three dimensional thermal field reconstruction. READ MORE
Strahlentherapie und Onkologie
PURPOSE: We retrospectively evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) combined with trans-arterial chemoembolization (TACE) as initial therapy in Barcelona Clinic Liver Cancer (BCLC) system stage B-C hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Seventy-two patients received a single dose of TACE followed by SBRT 4 weeks later. All patients had tumor sizes ≥5 cm, at least 700 ml of disease-free liver, Child-Pugh (CP) score ≤ B7 and tumor nodules ≤5. SBRT dose, ranging from 6 × 5-8 Gy or 5-10 × 4 Gy, was individualized according to normal tissue constraints. READ MORE |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063 |
